Masimo (MASI) Enters Amended Settlement with Nellcor; Medtronic (MDT) Will Continue Making Payments
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Masimo (NASDAQ: MASI) announced an amendment to the existing settlement agreement initially reached between Masimo and Nellcor in January 2006. Under the terms of the amendment, Medtronic (NYSE: MDT) will continue to pay Masimo a royalty of 7.75% for its current pulse oximetry products sold in the United States through October 6, 2018, after which no further royalties will be due under the agreement. For more information, please see the related Form 8-K filed with the Securities and Exchange Commission on September 2, 2016.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Overseas Shipholding Group (OSG) Reaches Agreement with SEC
- TerraForm Power (TERP) Enters Exclusivity Agreement with Brookfield Asset Management Regarding Possible Deal
- Cascadian Therapeutics (CASC) Plans Public Offerings of Common Stock and Preferred Stock
Create E-mail Alert Related CategoriesCorporate News, Litigation
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!